Latest News
Via The Motley Fool · May 14, 2025
Via The Motley Fool · May 14, 2025
Via The Motley Fool · May 14, 2025
Via The Motley Fool · May 14, 2025
Via The Motley Fool · May 14, 2025
A potential wild card is on the horizon.
Via The Motley Fool · May 14, 2025
Investors are bullish on this AI defense contractor. The numbers tell a different story.
Via The Motley Fool · May 14, 2025
Via The Motley Fool · May 14, 2025
Via The Motley Fool · May 14, 2025
FUTU HOLDINGS LTD-ADR (NASDAQ:FUTU) offers strong growth, solid profitability, and reasonable valuation, making it a compelling choice for investors seeking growth at a sensible price.
Via Chartmill · May 14, 2025
Via The Motley Fool · May 14, 2025
The daily chart signals a bullish trend for the S&P BSE Sensex, characterized by a strong impulsive structure.
Via Talk Markets · May 14, 2025
Via The Motley Fool · May 14, 2025
RTX CORP (NYSE:RTX) shows strong technicals and a promising breakout setup, supported by upward trends and consolidation near resistance. A potential entry point exists above $133.00.
Via Chartmill · May 14, 2025
This brand-name business has split its stock a staggering 14 times in less than 50 years.
Via The Motley Fool · May 14, 2025
Via The Motley Fool · May 14, 2025
Tesla Inc. CEO Elon Musk revealed that both Saudi Crown Prince Mohammed bin Salman and former U.S. President Donald Trump were impressed by the company's Optimus humanoid robot during a demonstration in Riyadh where the robot danced to "YMCA."
Via Benzinga · May 14, 2025
BIOMARIN PHARMACEUTICAL (NASDAQ:BMRN) is an undervalued biotech stock with strong profitability, solid financial health, and reasonable growth prospects, making it a candidate for value investors.
Via Chartmill · May 14, 2025